Simultaneous Delivery of Cancer Treatment Programs to Tumor and Immune Cells
Invention type: Technology
/
Case number: #22351
Disclosed herein are genetically modified herpesviruses for the treatment of cancer. Also provided are methods of treating cancer using genetically modified herpesviruses.
Researchers
Ron Weiss
/
Jin Huh
/
Yingzhong Li
Departments: Department of Biological Engineering
Technology Areas: Biotechnology: Synthetic Biology / Drug Delivery: Vectors & Virus like Particles / Therapeutics: Nucleic Acids
Impact Areas: Healthy Living
-
simultaneous delivery of cancer treatment programs to tumor and immune cells
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.